What to Expect After PRP Injection in Shoulder

Most people feel increased soreness and swelling at the injection site for the first two to three days after a PRP (platelet-rich plasma) injection in the shoulder, followed by a gradual improvement in pain and function that typically becomes noticeable around six to twelve weeks. The trajectory is not a straight line, though. The first few days can actually feel worse than before the injection, and certain medications you normally reach for are off-limits during that window. Understanding the full arc from injection day through long-term recovery helps set realistic expectations and avoid decisions that could undermine the treatment.

The First 48 Hours

The injection itself is a quick office procedure, but the immediate aftermath catches some people off guard. PRP works by delivering a concentrated dose of your own platelets and growth factors to damaged tissue, and the body’s inflammatory response to that concentrated mixture is the whole point. That means soreness, swelling, and sometimes a dull ache at the injection site are not signs that something went wrong. A randomized trial comparing different PRP formulations for shoulder periarthritis found that post-injection swelling and pain were the most commonly reported adverse events, and they were self-limiting and transient.¹ In that study, the post-injection protocol called for relative rest, ice, compression, and elevation (the RICE regimen) for the first couple of days, along with limiting overhead and strenuous activity.

One practical point trips people up more than anything else during this window: you should avoid non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen for at least the first 48 hours, and many clinicians recommend avoiding them for one to two weeks. Acetaminophen (paracetamol) is the go-to for pain relief instead.¹ The reasoning is straightforward: NSAIDs suppress the inflammatory cascade that PRP is designed to trigger. A systematic review examining how common medications affect platelet function found that drugs inhibiting platelet aggregation can blunt the release of key growth factors that PRP relies on to do its job.² If you are on blood thinners or daily aspirin for a heart condition, this is a conversation to have with both your orthopedic provider and your prescribing physician before the procedure, not after.

The Recovery Arc From Weeks to Months

After the initial flare settles down, there is often a quiet period where the shoulder does not feel dramatically better or worse. This plateau can last a few weeks and sometimes discourages people who expected quick results. PRP is not a cortisone shot; it does not suppress inflammation to provide fast relief. Instead, it delivers growth factors and anti-inflammatory mediators that support tissue repair over time.³ That biological process takes weeks to gain momentum.

The clearest evidence for when you can expect to notice a difference comes from a double-blind randomized trial comparing PRP to cortisone injections in patients with partial-thickness rotator cuff tears or tendinopathy. At six weeks, there was no measurable difference between the groups. By three months, the PRP group had pulled clearly ahead in pain scores, overall shoulder function, and a quality-of-life measure specific to rotator cuff disease.⁴ That three-month mark is a useful mental milestone: if you are not seeing meaningful improvement by then, it is worth re-evaluating with your provider rather than waiting indefinitely.

A meta-analysis pooling data from multiple trials of PRP for partial-thickness rotator cuff tears confirmed the pattern, finding that PRP outperformed placebo for both pain and shoulder function at the 8-to-12-week mark and again beyond 24 weeks.⁵ So the science supports patience through those first several weeks, but also supports expecting concrete improvement well before the six-month mark.

Physical Therapy and Getting Back to Normal Activity

PRP is almost never a standalone treatment. Most protocols pair the injection with a structured course of physical therapy, and the combination appears to matter. A pilot trial randomized patients with supraspinatus tendinopathy into groups receiving physical therapy alone, physical therapy with a steroid injection, physical therapy with a nerve block, or physical therapy with PRP. All participants followed a standardized 12-week physical therapy program. The group receiving physical therapy plus PRP showed improvement across pain, sleep quality, and shoulder function over the three-month follow-up.⁶

The typical rehabilitation timeline after a shoulder PRP injection involves a few phases. During the first one to two weeks, most clinicians restrict activity to gentle range-of-motion exercises and daily activities below shoulder height. From weeks two through six, guided strengthening exercises are gradually introduced. After six weeks, most people can return to more demanding activities, with full return to sport or heavy labor usually cleared somewhere between three and six months depending on the severity of the original injury and individual healing.

Athletes who needed only one injection and had a lower-grade or more acute injury tended to return to sports sooner than those who needed multiple injections for chronic problems.⁷ That finding makes intuitive sense: a fresher, smaller injury has an easier repair job ahead of it. If your shoulder problem has been developing for years, tempering your timeline expectations is wise.

How Results Differ by Shoulder Condition

The shoulder is not one uniform structure, and the reason for your PRP injection shapes what you should expect. The two most common shoulder indications are rotator cuff problems (tears and tendinopathy) and adhesive capsulitis (frozen shoulder), and the evidence base looks somewhat different for each.

Rotator Cuff Tears and Tendinopathy

For partial-thickness rotator cuff tears, PRP has the most data. One study comparing PRP injection to surgical repair for high-grade partial tears found that PRP patients improved from an average shoulder function score of about 53 out of 100 to nearly 93 at two-year follow-up, matching surgical outcomes with a shorter recovery period.⁸ That is an encouraging result, though it is worth noting the limitations. A systematic review examining PRP for partial tears concluded that while PRP reliably reduces pain in both the short and long term, the functional improvements are less consistent and may not hold up as strongly over time.⁹ Put plainly: you will likely hurt less, but whether you will gain back full strength and range of motion is harder to predict.

Frozen Shoulder

For adhesive capsulitis, the picture is more consistently positive. A systematic review of 19 studies found that PRP improved range of motion compared to baseline in every study that measured it, and in over 90 percent of direct comparisons between PRP and control groups, the PRP group had greater range of motion at the final follow-up.¹⁰ Pain scores and disability questionnaires also favored PRP across these studies. A separate meta-analysis found that PRP produced better pain relief than other non-surgical treatments at both one and three months.¹¹

When compared head-to-head with steroid injections for frozen shoulder, PRP showed advantages specifically in internal rotation and overall disability scores at three months, though pain levels between the two groups were similar.¹² If your main complaint is stiffness rather than pain, PRP may have a particular edge over cortisone.

Not All PRP Is the Same

One reason results vary so much from study to study and from clinic to clinic is that PRP is not a single standardized product. The preparation method, the centrifuge used, and whether white blood cells are included or filtered out all change what ends up in the syringe. The two broad categories are leukocyte-rich PRP (LR-PRP), which contains white blood cells, and leukocyte-poor PRP (LP-PRP), which filters most of them out.

An umbrella review of meta-analyses examining PRP in rotator cuff surgery found that leukocyte-poor PRP reduced retear rates, eased pain, and improved some function scores compared to no PRP.¹³ Leukocyte-rich PRP, on the other hand, showed limited benefit beyond a modest improvement on one shoulder test. A separate meta-analysis specifically examining retear rates after arthroscopic rotator cuff repair reached a similar conclusion: leukocyte-poor PRP cut retear rates roughly in half and improved multiple clinical scores, while leukocyte-rich PRP did not perform clearly better than controls except for pain.¹⁴

This matters practically. The first trial mentioned in this article found that leukocyte-rich PRP caused more post-injection swelling and pain, which aligns with the idea that white blood cells drive a more aggressive inflammatory response.¹ If you are offered PRP, asking your provider whether they use a leukocyte-rich or leukocyte-poor preparation is a reasonable question. Not every clinic advertises this, and many patients do not know to ask.

Complications and Red Flags to Watch For

PRP’s overall complication rate is low and comparable to other injectable treatments for the shoulder. A meta-analysis of randomized controlled trials found no difference in the total complication rate between PRP and other injectables (roughly 9 to 10 percent in each group).¹⁵ The most commonly reported issues were persistent pain, worsening of a tear, and bursitis. One finding that stands out, though, is that PRP patients had a higher rate of developing frozen shoulder than patients receiving other injectables.¹⁵ The irony that PRP can both treat frozen shoulder and occasionally trigger it in rotator cuff patients is not well explained yet, but the risk appears to be linked to the inflammatory surge PRP creates.

Signs that warrant calling your provider include fever, spreading redness around the injection site, increasing pain that has not begun to ease by the fourth or fifth day, or sudden significant loss of range of motion in the weeks following the injection. Because PRP uses your own blood, infection risk is lower than with some other injectables, but it is not zero. Any injection through the skin carries some risk, and a shoulder joint infection requires urgent treatment.

Factors That Influence Your Outcome

Not everyone responds to PRP equally, and understanding what tips the odds can help you set realistic expectations. Several patient-specific and injury-specific factors matter.

Age is among the most discussed. Older adults may respond less robustly to PRP because their baseline tissue-regeneration capacity is lower.¹⁶ That does not mean PRP is ineffective for someone in their sixties or seventies, but the magnitude of improvement may be smaller. Smoking, diabetes, and the chronicity and size of a rotator cuff tear are also established risk factors for poorer tendon healing.¹⁷ Fatty infiltration of the rotator cuff muscles, where the muscle is replaced by fat over time, is another sign that the tissue’s repair potential is compromised.¹⁷

If you smoke, quitting (or at least stopping for a period around the injection) gives you the best chance of a good response. If you have diabetes, optimizing blood-sugar control in the weeks surrounding the procedure is another variable you can influence. These are not guarantees, but they are the modifiable factors that the evidence points to.

One Injection or More

You will often hear different protocols: some providers recommend a single injection and others recommend a series of two or three, spaced a few weeks apart. A double-blind trial specifically comparing single PRP injection to multiple PRP injections for rotator cuff syndrome found that both approaches improved quality-of-life scores more than a sham injection, but there was no significant difference between the single and multiple injection groups.¹⁸ That suggests a single injection may be sufficient for many patients, though some clinicians still prefer a series for more severe or chronic cases. Given the cost implications (discussed below), starting with one injection and reassessing is a reasonable approach.

What MRI Looks Like After PRP

If you get a follow-up MRI after PRP, do not be alarmed if the images do not show dramatic structural change. A trial comparing PRP to cortisone for symptomatic partial rotator cuff tears found only a slight, non-significant improvement in tendon appearance on MRI in both groups.¹⁹ This is a common source of frustration. Patients feel better, their function improves, but the MRI looks essentially the same. The disconnect likely reflects the fact that pain and function are driven by more than just the structural integrity visible on imaging. Reduced inflammation, improved tendon quality at a microscopic level, and nerve desensitization can all improve symptoms without an obvious change on a scan. Your provider should be evaluating your progress primarily by how your shoulder feels and performs, not by imaging alone.

Does Image Guidance During the Injection Matter

PRP can be injected using anatomical landmarks alone (the provider feels for structures and estimates placement) or under ultrasound guidance, where the needle is visible on screen in real time. An umbrella review comparing the two approaches for musculoskeletal injections found that ultrasound-guided injections were more accurate than landmark-guided ones, with the shoulder joint being one of the areas where accuracy improved most.²⁰ A focused systematic review of shoulder girdle injections specifically confirmed that ultrasound guidance improved accuracy for most shoulder targets, with the exception of the subacromial space (where landmark-guided injections are already quite accurate).²¹

If your PRP is being directed into a specific tear or into the glenohumeral joint capsule for frozen shoulder, ultrasound guidance is worth asking about. For a subacromial injection, the benefit is less clear. Some providers charge more for ultrasound-guided procedures, so knowing where the injection is going helps you weigh whether the added accuracy justifies the cost.

Cost, Insurance, and the Regulatory Landscape

PRP sits in an unusual regulatory space. It is FDA-cleared as a device (the kits used to prepare it are cleared), but it is not FDA-approved as a drug for any specific indication. That distinction means most insurers consider PRP experimental and do not cover it. Out-of-pocket costs for a single shoulder PRP treatment typically run between $500 and $2,500, with many patients returning for at least one additional session.²² That can mean $1,000 to $5,000 or more out of pocket if a multi-injection protocol is recommended.

Before committing, it is fair to ask your provider a few direct questions: what PRP formulation they use, whether they use image guidance, how many injections they typically recommend, and what their own patients’ outcomes look like. The lack of standardization across clinics means the PRP you receive at one practice may differ meaningfully from what is prepared at another, and those differences can affect both recovery and results.

Long-Term Durability

A common concern is whether the benefits of PRP fade after a year or two. The answer depends partly on whether PRP was used on its own or as an add-on to surgery. In the context of arthroscopic rotator cuff repair, a randomized trial found no significant difference between PRP and control groups at 6, 12, or 24 months in terms of healing rates or overall function scores, though a subgroup of patients with smaller tears showed persistent benefit from PRP at all time points through two years.²³ Another study of PRP used during single-row rotator cuff repair found that both PRP and control groups improved steadily through 24 months, with patient satisfaction around 95 percent in both groups, but no meaningful difference between them.²⁴

These surgical studies suggest that when PRP is layered on top of an already effective surgical repair, the added benefit is modest at best over the long term. The more compelling long-term case for PRP is as a non-surgical option, where the comparison is not “surgery plus PRP vs. surgery alone” but rather “PRP vs. continuing to live with the problem or getting a cortisone shot.” In that context, the three-month gains documented in the trial comparing PRP to cortisone are meaningful, because cortisone’s effects tend to wear off within weeks while PRP’s appear to build. The earlier-cited trial showed no difference between groups at 12 months, suggesting eventual convergence, but the patient who avoids surgery and cortisone dependency along the way may still consider PRP a worthwhile choice.⁴